Tanım

Cell therapies aims to introduce new, healthy cells into a patient’s body, to replace the diseased or missing ones. Manufacturing them involves collecting a specific set of cells from the blood, modifying them to produce a more vigorous attack on a patient’s cancer cells, and then reinjecting them into the patient. The global cell therapy biomanufacturing market is set to increase by US$ 4.4 billion from 2022 ile 2028, representing a compound annual growth rate (CAGR) ile ilgili 8.8% tahmin dönemi boyunca.

Rapor, döneme ilişkin güncel pazar büyüklüğü verilerini sağlar 2018-2021 ve tahmin 2028 covering key market aspects like sales value for cell therapy biomanufacturing. The global cell therapy biomanufacturing market is segmented on the basis of application, ve bölge. On the basis of application, the global cell therapy biomanufacturing market has been segmented into bone repair, cancer, cardiovascular diseases, neurological disorders, skeletal muscle repair, diğerleri. Bunların arasında, the skeletal muscle repair segment was accounted for the highest revenue generator in 2021. In terms of geography, the global cell therapy biomanufacturing market has been segmented into Asia Pacific, Avrupa, Kuzey Amerika, MEA (Orta Doğu ve Afrika), Latin Amerika. North America is estimated to account for the largest share of the global cell therapy biomanufacturing market.

The global cell therapy biomanufacturing market is highly competitive. itibariyle 2021, the major players in the global cell therapy biomanufacturing market were Bone Therapeutics S.A., Caladrius Biosciences Inc., Iovance Biotherapeutics Inc., Lonza Group AG, Merck KGaA, Novartis AG, Regen BioPharma Inc., Regeneus Ltd., The Bristol-Myers Squibb Company (BMS).

Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the cell therapy biomanufacturing market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.

Rapor Kapsamı

Başvuru: bone repair, cancer, cardiovascular diseases, neurological disorders, skeletal muscle repair, diğerleri
Bölge: Asya Pasifik, Avrupa, Kuzey Amerika, MEA (Orta Doğu ve Afrika), Latin Amerika
Dikkate alınan yıllar: bu rapor dönemi kapsamaktadır 2018 ile 2028

Paydaşlar için Temel Faydalar

– Get a comprehensive picture of the global cell therapy biomanufacturing market
– Büyüme sektörlerini ve yatırım eğilimlerini belirleyin

İçindekiler

Parça 1. giriiş
– Çalışmanın kapsamı
– Çalışma periyodu
– Coğrafik kapsam
– Araştırma metodolojisi
Parça 2. Cell therapy biomanufacturing market overview
Parça 3. Market breakdown by application
– Bone repair
– Cancer
– Cardiovascular diseases
– Neurological disorders
– Skeletal muscle repair
– Diğerleri
Parça 4. Market breakdown by region
– Asya Pasifik
– Avrupa
– Kuzey Amerika
– MEA (Orta Doğu ve Afrika)
– Latin Amerika
Parça 5. Anahtar şirketler
– Bone Therapeutics S.A.
– Caladrius Biosciences, A.Ş..
– Iovance Biotherapeutics, A.Ş..
– Lonza Group AG
– Merck KGaA
– Novartis AG
– Regen BioPharma, A.Ş..
– Regeneus Ltd.
– The Bristol-Myers Squibb Company (BMS)
StratejiHelix Hakkında
Sorumluluk reddi beyanı